THOUSANDS of deaths from colon cancer could be prevented by a drug that wipes
out rogue polyps in the lower bowel. The drug, called exisulind, has been
submitted for approval to the US Food and Drug Administration and may get the
green light before the end of the year.
If an American licence is followed by European approval it could provide a
new source of controversy for Britain’s cash-strapped National Health Service,
experts warn. John Burn, professor of clinical genetics at the University of
Newcastle upon Tyne, told Â鶹´«Ã½ that cost would be a “major
factor” in deciding whether…
